SCHEMBL2739489

SCHEMBL2739489

NC[C@H](N)C(=O)NCC(N)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 3/20 0.36
DPP4 P27487 2/20 0.36
DPP9 Q86TI2 2/20 0.36
RRM1 P23921 1/20 0.34
METAP1 P53582 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
GNAI3 P08754 1/20 0.33
GNAO1 P09471 1/20 0.33
GNAI1 P63096 1/20 0.33
ALOX15 P16050 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
KMT2A Q03164 1/20 0.32
DPP8 Q6V1X1 1/20 0.31
TERT O14746 1/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633077 1.00 DPP7 (0.36) DPP7DPP4DPP9RRM1METAP1
SCHEMBL1274426 0.82 CA12 (0.35) DPP7DPP4DPP9RRM1METAP1
SCHEMBL2189880 0.82 CA12 (0.35) DPP7DPP4DPP9RRM1METAP1
SCHEMBL2739680 0.82 ALDH1A1 (0.48) DPP7DPP4DPP9BLMKMT2A
SCHEMBL2739537 0.82 ALDH1A1 (0.48) DPP7DPP4DPP9BLMKMT2A
SCHEMBL2739441 0.82 ALDH1A1 (0.48) DPP7DPP4DPP9BLMKMT2A
SCHEMBL20807626 0.80 PTGS1 (0.44) DPP7METAP1ALOX15BLMPMP22
SCHEMBL21153856 0.80 PTGS1 (0.44) DPP7METAP1ALOX15BLMPMP22
SCHEMBL24709575 0.78 SLC22A6 (0.37) ALOX15BLMPMP22KMT2AALDH1A1
SCHEMBL7541728 0.78 BLM (0.54) DPP7DPP4DPP9RRM1METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512176-B2 Age inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-12-06 US disclosed
EP-1863832-B1 AGE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-01-04 EP disclosed
US-20080249030-A1 Age Inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-10-09 US disclosed
WO-2006103274-A9 AGE INHIBITORS PHARMAMENS (FR) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249030-A1 Age Inhibitors CFH, XPA, XPNPEP1 DPP7 3818/4885DPP4 3617/4885DPP9 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.